{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,4]],"date-time":"2026-08-04T16:16:44Z","timestamp":1785860204542,"version":"3.56.0"},"reference-count":54,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,3,18]],"date-time":"2021-03-18T00:00:00Z","timestamp":1616025600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2021,3,18]],"date-time":"2021-03-18T00:00:00Z","timestamp":1616025600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Ministry of Science and Technology, Executive Yuan","award":["MOST 109-2314-B-075B-014 -MY2"],"award-info":[{"award-number":["MOST 109-2314-B-075B-014 -MY2"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Anti-Mullerian hormone (AMH) and testosterone (T) both play distinct roles in the early stages of folliculogenesis. However, the relationship between serum T and AMH levels is poorly understood. This study aimed to investigate the association between serum T and AMH levels in infertile women. A total of 1935 infertile women aged 20\u201346\u00a0years were included in the cross-sectional study and divided into four quartile groups (Q1 to Q4) based on serum T levels. Compared to the subjects in the highest T quartile (Q4), those in the lowest T quartile (Q1) showed significantly lower AMH levels. After adjustment for age, body weight, body mass index and FSH, increasing T quartile categories were associated with higher AMH levels. Binary logistic regression analyses revealed that the odds for the risk of diminished ovarian reserve (DOR) were 11.44-fold higher in Q1 than in Q4 and the odds for the risk of excess ovarian reserve (EOR) were 10.41-fold higher in Q4 than in Q1. Our data show that serum T levels are positively associated with serum AMH levels and suggest that androgen insufficiency may be a potential risk factor for DOR; androgen excess may lead to EOR in infertile women.<\/jats:p>","DOI":"10.1038\/s41598-021-85915-x","type":"journal-article","created":{"date-parts":[[2021,3,18]],"date-time":"2021-03-18T12:47:41Z","timestamp":1616071661000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":16,"title":["Serum testosterone levels are positively associated with serum anti-mullerian hormone levels in infertile women"],"prefix":"10.1038","volume":"11","author":[{"given":"Li-Te","family":"Lin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chia-Jung","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kuan-Hao","family":"Tsui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,3,18]]},"reference":[{"key":"85915_CR1","doi-asserted-by":"publisher","first-page":"370","DOI":"10.1093\/humupd\/dmt062","volume":"20","author":"D Dewailly","year":"2014","unstructured":"Dewailly, D. et al. The physiology and clinical utility of anti-Mullerian hormone in women. Hum. Reprod. Update 20, 370\u2013385. https:\/\/doi.org\/10.1093\/humupd\/dmt062 (2014).","journal-title":"Hum. Reprod. Update"},{"key":"85915_CR2","doi-asserted-by":"publisher","first-page":"519","DOI":"10.1093\/molehr\/gat024","volume":"19","author":"JV Jeppesen","year":"2013","unstructured":"Jeppesen, J. V. et al. Which follicles make the most anti-Mullerian hormone in humans? Evidence for an abrupt decline in AMH production at the time of follicle selection. Mol. Hum. Reprod. 19, 519\u2013527. https:\/\/doi.org\/10.1093\/molehr\/gat024 (2013).","journal-title":"Mol. Hum. Reprod."},{"key":"85915_CR3","doi-asserted-by":"publisher","DOI":"10.1210\/clinem\/dgaa513","author":"LME Moolhuijsen","year":"2020","unstructured":"Moolhuijsen, L. M. E. & Visser, J. A. Anti-mullerian hormone and ovarian reserve: Update on assessing ovarian function. J. Clin. Endocrinol. Metab. https:\/\/doi.org\/10.1210\/clinem\/dgaa513 (2020).","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"85915_CR4","doi-asserted-by":"publisher","first-page":"e22024","DOI":"10.1371\/journal.pone.0022024","volume":"6","author":"TW Kelsey","year":"2011","unstructured":"Kelsey, T. W., Wright, P., Nelson, S. M., Anderson, R. A. & Wallace, W. H. A validated model of serum anti-m\u00fcllerian hormone from conception to menopause. PLoS ONE 6, e22024. https:\/\/doi.org\/10.1371\/journal.pone.0022024 (2011).","journal-title":"PLoS ONE"},{"key":"85915_CR5","doi-asserted-by":"publisher","first-page":"4650","DOI":"10.1210\/jc.2012-1440","volume":"97","author":"S Lie Fong","year":"2012","unstructured":"Lie Fong, S. et al. Serum anti-m\u00fcllerian hormone levels in healthy females: A nomogram ranging from infancy to adulthood. J. Clin. Endocrinol. Metab. 97, 4650\u20134655. https:\/\/doi.org\/10.1210\/jc.2012-1440 (2012).","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"85915_CR6","doi-asserted-by":"publisher","first-page":"420","DOI":"10.1016\/j.fertnstert.2013.04.024","volume":"100","author":"SL Broer","year":"2013","unstructured":"Broer, S. L. et al. Prediction of an excessive response in in vitro fertilization from patient characteristics and ovarian reserve tests and comparison in subgroups: An individual patient data meta-analysis. Fertil. Steril. 100, 420-429.e427. https:\/\/doi.org\/10.1016\/j.fertnstert.2013.04.024 (2013).","journal-title":"Fertil. Steril."},{"key":"85915_CR7","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1093\/humupd\/dms041","volume":"19","author":"SL Broer","year":"2013","unstructured":"Broer, S. L. et al. Added value of ovarian reserve testing on patient characteristics in the prediction of ovarian response and ongoing pregnancy: An individual patient data approach. Hum. Reprod. Update 19, 26\u201336. https:\/\/doi.org\/10.1093\/humupd\/dms041 (2013).","journal-title":"Hum. Reprod. Update"},{"key":"85915_CR8","doi-asserted-by":"publisher","first-page":"2693","DOI":"10.1002\/14651858.CD012693.pub2","volume":"2","author":"SF Lensen","year":"2018","unstructured":"Lensen, S. F. et al. Individualised gonadotropin dose selection using markers of ovarian reserve for women undergoing in vitro fertilisation plus intracytoplasmic sperm injection (IVF\/ICSI). Cochrane Database Syst. Rev. 2, 2693. https:\/\/doi.org\/10.1002\/14651858.CD012693.pub2 (2018).","journal-title":"Cochrane Database Syst. Rev."},{"key":"85915_CR9","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1093\/hropen\/hoz003","volume":"2019","author":"J Friis Petersen","year":"2019","unstructured":"Friis Petersen, J. et al. A randomized controlled trial of AMH-based individualized FSH dosing in a GnRH antagonist protocol for IVF. Hum. Reprod. Open 2019, 3. https:\/\/doi.org\/10.1093\/hropen\/hoz003 (2019).","journal-title":"Hum. Reprod. Open"},{"key":"85915_CR10","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1016\/j.mce.2017.06.026","volume":"465","author":"KA Walters","year":"2018","unstructured":"Walters, K. A. & Handelsman, D. J. Role of androgens in the ovary. Mol. Cell. Endocrinol. 465, 36\u201347. https:\/\/doi.org\/10.1016\/j.mce.2017.06.026 (2018).","journal-title":"Mol. Cell. Endocrinol."},{"key":"85915_CR11","doi-asserted-by":"publisher","first-page":"1166","DOI":"10.1210\/en.2019-00101","volume":"160","author":"O Astapova","year":"2019","unstructured":"Astapova, O., Minor, B. M. N. & Hammes, S. R. Physiological and pathological androgen actions in the ovary. Endocrinology 160, 1166\u20131174. https:\/\/doi.org\/10.1210\/en.2019-00101 (2019).","journal-title":"Endocrinology"},{"key":"85915_CR12","doi-asserted-by":"publisher","first-page":"363","DOI":"10.1016\/s0960-0760(03)00204-8","volume":"85","author":"SL Davison","year":"2003","unstructured":"Davison, S. L. & Davis, S. R. Androgens in women. J. Steroid Biochem. Mol. Biol. 85, 363\u2013366. https:\/\/doi.org\/10.1016\/s0960-0760(03)00204-8 (2003).","journal-title":"J. Steroid Biochem. Mol. Biol."},{"key":"85915_CR13","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1093\/humrep\/12.1.107","volume":"12","author":"SG Hillier","year":"1997","unstructured":"Hillier, S. G., Tetsuka, M. & Fraser, H. M. Location and developmental regulation of androgen receptor in primate ovary. Hum. Reprod. 12, 107\u2013111. https:\/\/doi.org\/10.1093\/humrep\/12.1.107 (1997).","journal-title":"Hum. Reprod."},{"key":"85915_CR14","doi-asserted-by":"publisher","first-page":"3847","DOI":"10.1210\/jc.2005-0212","volume":"90","author":"SL Davison","year":"2005","unstructured":"Davison, S. L., Bell, R., Donath, S., Montalto, J. G. & Davis, S. R. Androgen levels in adult females: Changes with age, menopause, and oophorectomy. J. Clin. Endocrinol. Metab. 90, 3847\u20133853. https:\/\/doi.org\/10.1210\/jc.2005-0212 (2005).","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"85915_CR15","doi-asserted-by":"publisher","first-page":"145","DOI":"10.12717\/dr.2014.18.3.145","volume":"18","author":"CH Kim","year":"2014","unstructured":"Kim, C. H. et al. Ovarian features after 2 weeks, 3 weeks and 4 weeks transdermal testosterone gel treatment and their associated effect on IVF outcomes in poor responders. Dev. Reprod. 18, 145\u2013152. https:\/\/doi.org\/10.12717\/dr.2014.18.3.145 (2014).","journal-title":"Dev. Reprod."},{"key":"85915_CR16","doi-asserted-by":"publisher","first-page":"679","DOI":"10.1016\/j.fertnstert.2010.07.1077","volume":"95","author":"CH Kim","year":"2011","unstructured":"Kim, C. H., Howles, C. M. & Lee, H. A. The effect of transdermal testosterone gel pretreatment on controlled ovarian stimulation and IVF outcome in low responders. Fertil. Steril. 95, 679\u2013683. https:\/\/doi.org\/10.1016\/j.fertnstert.2010.07.1077 (2011).","journal-title":"Fertil. Steril."},{"key":"85915_CR17","doi-asserted-by":"publisher","first-page":"80","DOI":"10.5468\/ogs.2020.63.1.80","volume":"63","author":"CH Park","year":"2020","unstructured":"Park, C. H. & Chun, S. Influence of combined oral contraceptives on polycystic ovarian morphology-related parameters in Korean women with polycystic ovary syndrome. Obstet. Gynecol. Sci. 63, 80\u201386. https:\/\/doi.org\/10.5468\/ogs.2020.63.1.80 (2020).","journal-title":"Obstet. Gynecol. Sci."},{"key":"85915_CR18","doi-asserted-by":"publisher","first-page":"612","DOI":"10.3109\/09513590.2016.1145647","volume":"32","author":"P Plouvier","year":"2016","unstructured":"Plouvier, P. et al. Is the suppressive effect of cyproterone acetate on serum anti-M\u00fcllerian-hormone levels in women with polycystic ovary syndrome stronger than under oral contraceptive pill?. Gynecol. Endocrinol. 32, 612\u2013616. https:\/\/doi.org\/10.3109\/09513590.2016.1145647 (2016).","journal-title":"Gynecol. Endocrinol."},{"key":"85915_CR19","doi-asserted-by":"publisher","first-page":"2622","DOI":"10.1172\/jci2081","volume":"101","author":"KA Vendola","year":"1998","unstructured":"Vendola, K. A., Zhou, J., Adesanya, O. O., Weil, S. J. & Bondy, C. A. Androgens stimulate early stages of follicular growth in the primate ovary. J. Clin. Invest. 101, 2622\u20132629. https:\/\/doi.org\/10.1172\/jci2081 (1998).","journal-title":"J. Clin. Invest."},{"key":"85915_CR20","doi-asserted-by":"publisher","first-page":"3008","DOI":"10.1073\/pnas.1318978111","volume":"111","author":"A Sen","year":"2014","unstructured":"Sen, A. et al. Androgens regulate ovarian follicular development by increasing follicle stimulating hormone receptor and microRNA-125b expression. Proc. Natl. Acad. Sci. U.S.A. 111, 3008\u20133013. https:\/\/doi.org\/10.1073\/pnas.1318978111 (2014).","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"85915_CR21","doi-asserted-by":"publisher","first-page":"920","DOI":"10.1210\/en.2016-1538","volume":"158","author":"M Laird","year":"2017","unstructured":"Laird, M. et al. Androgen stimulates growth of mouse preantral follicles in vitro: interaction with follicle-stimulating hormone and with growth factors of the TGF\u03b2 superfamily. Endocrinology 158, 920\u2013935. https:\/\/doi.org\/10.1210\/en.2016-1538 (2017).","journal-title":"Endocrinology"},{"key":"85915_CR22","doi-asserted-by":"publisher","first-page":"825","DOI":"10.1095\/biolreprod.104.039362","volume":"73","author":"TE Hickey","year":"2005","unstructured":"Hickey, T. E. et al. Androgens augment the mitogenic effects of oocyte-secreted factors and growth differentiation factor 9 on porcine granulosa cells. Biol. Reprod. 73, 825\u2013832. https:\/\/doi.org\/10.1095\/biolreprod.104.039362 (2005).","journal-title":"Biol. Reprod."},{"key":"85915_CR23","doi-asserted-by":"publisher","first-page":"656","DOI":"10.1210\/me.2010-0367","volume":"25","author":"YG Wu","year":"2011","unstructured":"Wu, Y. G., Bennett, J., Talla, D. & Stocco, C. Testosterone, not 5\u03b1-dihydrotestosterone, stimulates LRH-1 leading to FSH-independent expression of Cyp19 and P450scc in granulosa cells. Mol. Endocrinol. 25, 656\u2013668. https:\/\/doi.org\/10.1210\/me.2010-0367 (2011).","journal-title":"Mol. Endocrinol."},{"key":"85915_CR24","doi-asserted-by":"publisher","first-page":"774","DOI":"10.1210\/en.2009-0751","volume":"151","author":"JL Yang","year":"2010","unstructured":"Yang, J. L. et al. Testosterone induces redistribution of forkhead box-3a and down-regulation of growth and differentiation factor 9 messenger ribonucleic acid expression at early stage of mouse folliculogenesis. Endocrinology 151, 774\u2013782. https:\/\/doi.org\/10.1210\/en.2009-0751 (2010).","journal-title":"Endocrinology"},{"key":"85915_CR25","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1095\/biolreprod61.2.353","volume":"61","author":"K Vendola","year":"1999","unstructured":"Vendola, K. et al. Androgens promote oocyte insulin-like growth factor I expression and initiation of follicle development in the primate ovary. Biol. Reprod. 61, 353\u2013357. https:\/\/doi.org\/10.1095\/biolreprod61.2.353 (1999).","journal-title":"Biol. Reprod."},{"key":"85915_CR26","doi-asserted-by":"publisher","first-page":"1084","DOI":"10.1093\/humrep\/det033","volume":"28","author":"N Gleicher","year":"2013","unstructured":"Gleicher, N. et al. Hypoandrogenism in association with diminished functional ovarian reserve. Hum. Reprod. 28, 1084\u20131091. https:\/\/doi.org\/10.1093\/humrep\/det033 (2013).","journal-title":"Hum. Reprod."},{"key":"85915_CR27","doi-asserted-by":"publisher","first-page":"458","DOI":"10.3389\/fendo.2019.00458","volume":"10","author":"A Fuentes","year":"2019","unstructured":"Fuentes, A. et al. Androgens profile in blood serum and follicular fluid of women with poor ovarian response during controlled ovarian stimulation reveals differences amongst POSEIDON stratification groups: A pilot study. Front. Endocrinol. 10, 458. https:\/\/doi.org\/10.3389\/fendo.2019.00458 (2019).","journal-title":"Front. Endocrinol."},{"key":"85915_CR28","doi-asserted-by":"publisher","first-page":"3781","DOI":"10.1210\/en.2007-0168","volume":"148","author":"L Manner\u00e5s","year":"2007","unstructured":"Manner\u00e5s, L. et al. A new rat model exhibiting both ovarian and metabolic characteristics of polycystic ovary syndrome. Endocrinology 148, 3781\u20133791. https:\/\/doi.org\/10.1210\/en.2007-0168 (2007).","journal-title":"Endocrinology"},{"key":"85915_CR29","doi-asserted-by":"publisher","first-page":"3146","DOI":"10.1210\/en.2014-1196","volume":"155","author":"AS Caldwell","year":"2014","unstructured":"Caldwell, A. S. et al. Characterization of reproductive, metabolic, and endocrine features of polycystic ovary syndrome in female hyperandrogenic mouse models. Endocrinology 155, 3146\u20133159. https:\/\/doi.org\/10.1210\/en.2014-1196 (2014).","journal-title":"Endocrinology"},{"key":"85915_CR30","doi-asserted-by":"publisher","first-page":"645","DOI":"10.1210\/me.2010-0297","volume":"25","author":"J Taieb","year":"2011","unstructured":"Taieb, J. et al. FSH and its second messenger cAMP stimulate the transcription of human anti-M\u00fcllerian hormone in cultured granulosa cells. Mol. Endocrinol. 25, 645\u2013655. https:\/\/doi.org\/10.1210\/me.2010-0297 (2011).","journal-title":"Mol. Endocrinol."},{"key":"85915_CR31","doi-asserted-by":"publisher","first-page":"762","DOI":"10.1093\/humrep\/des460","volume":"28","author":"A Pierre","year":"2013","unstructured":"Pierre, A. et al. Loss of LH-induced down-regulation of anti-M\u00fcllerian hormone receptor expression may contribute to anovulation in women with polycystic ovary syndrome. Hum. Reprod. 28, 762\u2013769. https:\/\/doi.org\/10.1093\/humrep\/des460 (2013).","journal-title":"Hum. Reprod."},{"key":"85915_CR32","doi-asserted-by":"publisher","first-page":"4891","DOI":"10.1210\/endo.142.11.8486","volume":"142","author":"AL Durlinger","year":"2001","unstructured":"Durlinger, A. L. et al. Anti-M\u00fcllerian hormone attenuates the effects of FSH on follicle development in the mouse ovary. Endocrinology 142, 4891\u20134899. https:\/\/doi.org\/10.1210\/endo.142.11.8486 (2001).","journal-title":"Endocrinology"},{"key":"85915_CR33","doi-asserted-by":"publisher","first-page":"1246","DOI":"10.1016\/j.fertnstert.2011.08.015","volume":"96","author":"L Pellatt","year":"2011","unstructured":"Pellatt, L. et al. Anti-M\u00fcllerian hormone reduces follicle sensitivity to follicle-stimulating hormone in human granulosa cells. Fertil. Steril. 96, 1246-1251.e1241. https:\/\/doi.org\/10.1016\/j.fertnstert.2011.08.015 (2011).","journal-title":"Fertil. Steril."},{"key":"85915_CR34","doi-asserted-by":"publisher","first-page":"709","DOI":"10.1093\/humupd\/dmw027","volume":"22","author":"D Dewailly","year":"2016","unstructured":"Dewailly, D. et al. Interactions between androgens, FSH, anti-Mullerian hormone and estradiol during folliculogenesis in the human normal and polycystic ovary. Hum. Reprod. Update 22, 709\u2013724. https:\/\/doi.org\/10.1093\/humupd\/dmw027 (2016).","journal-title":"Hum. Reprod. Update"},{"key":"85915_CR35","doi-asserted-by":"publisher","first-page":"10055","DOI":"10.1038\/ncomms10055","volume":"7","author":"I Cimino","year":"2016","unstructured":"Cimino, I. et al. Novel role for anti-Mullerian hormone in the regulation of GnRH neuron excitability and hormone secretion. Nat. Commun. 7, 10055. https:\/\/doi.org\/10.1038\/ncomms10055 (2016).","journal-title":"Nat. Commun."},{"key":"85915_CR36","doi-asserted-by":"publisher","DOI":"10.1007\/s00018-020-03576-x","author":"MSB Silva","year":"2020","unstructured":"Silva, M. S. B. & Giacobini, P. New insights into anti-Mullerian hormone role in the hypothalamic-pituitary-gonadal axis and neuroendocrine development. Cell Mol. Life Sci. https:\/\/doi.org\/10.1007\/s00018-020-03576-x (2020).","journal-title":"Cell Mol. Life Sci."},{"key":"85915_CR37","doi-asserted-by":"publisher","first-page":"5957","DOI":"10.1210\/jc.2003-030727","volume":"88","author":"P Pigny","year":"2003","unstructured":"Pigny, P. et al. Elevated serum level of anti-mullerian hormone in patients with polycystic ovary syndrome: Relationship to the ovarian follicle excess and to the follicular arrest. J. Clin. Endocrinol. Metab. 88, 5957\u20135962. https:\/\/doi.org\/10.1210\/jc.2003-030727 (2003).","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"85915_CR38","doi-asserted-by":"publisher","first-page":"4399","DOI":"10.1210\/jc.2010-0334","volume":"95","author":"D Dewailly","year":"2010","unstructured":"Dewailly, D. et al. Reconciling the definitions of polycystic ovary syndrome: The ovarian follicle number and serum anti-M\u00fcllerian hormone concentrations aggregate with the markers of hyperandrogenism. J. Clin. Endocrinol. Metab. 95, 4399\u20134405. https:\/\/doi.org\/10.1210\/jc.2010-0334 (2010).","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"85915_CR39","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1186\/s12902-020-00569-6","volume":"20","author":"PP Lv","year":"2020","unstructured":"Lv, P. P. et al. Role of anti-Mullerian hormone and testosterone in follicular growth: A cross-sectional study. BMC Endocr. Disord. 20, 101. https:\/\/doi.org\/10.1186\/s12902-020-00569-6 (2020).","journal-title":"BMC Endocr. Disord."},{"key":"85915_CR40","doi-asserted-by":"publisher","first-page":"339","DOI":"10.1007\/s12020-009-9227-6","volume":"36","author":"N Crisosto","year":"2009","unstructured":"Crisosto, N. et al. Testosterone-induced downregulation of anti-M\u00fcllerian hormone expression in granulosa cells from small bovine follicles. Endocrine 36, 339\u2013345. https:\/\/doi.org\/10.1007\/s12020-009-9227-6 (2009).","journal-title":"Endocrine"},{"key":"85915_CR41","doi-asserted-by":"publisher","first-page":"1340","DOI":"10.1016\/j.fertnstert.2015.02.003","volume":"103","author":"MR Caanen","year":"2015","unstructured":"Caanen, M. R. et al. Antim\u00fcllerian hormone levels decrease in female-to-male transsexuals using testosterone as cross-sex therapy. Fertil. Steril. 103, 1340\u20131345. https:\/\/doi.org\/10.1016\/j.fertnstert.2015.02.003 (2015).","journal-title":"Fertil. Steril."},{"key":"85915_CR42","doi-asserted-by":"publisher","first-page":"2354","DOI":"10.1016\/j.fertnstert.2011.03.047","volume":"95","author":"Y Li","year":"2011","unstructured":"Li, Y., Wei, L. N. & Liang, X. Y. Follicle-stimulating hormone suppressed excessive production of antimullerian hormone caused by abnormally enhanced promoter activity in\u00a0polycystic ovary syndrome granulosa cells. Fertil. Steril. 95, 2354\u20132358. https:\/\/doi.org\/10.1016\/j.fertnstert.2011.03.047 (2011).","journal-title":"Fertil. Steril."},{"key":"85915_CR43","doi-asserted-by":"publisher","first-page":"829","DOI":"10.1007\/s10815-014-0246-8","volume":"31","author":"B Sun","year":"2014","unstructured":"Sun, B., Wang, F., Sun, J., Yu, W. & Sun, Y. Basal serum testosterone levels correlate with ovarian response but do not predict pregnancy outcome in non-PCOS women undergoing IVF. J. Assist. Reprod. Genet. 31, 829\u2013835. https:\/\/doi.org\/10.1007\/s10815-014-0246-8 (2014).","journal-title":"J. Assist. Reprod. Genet."},{"key":"85915_CR44","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1186\/1477-7827-9-9","volume":"9","author":"Y Qin","year":"2011","unstructured":"Qin, Y. et al. Association of basal serum testosterone levels with ovarian response and in vitro fertilization outcome. Reprod. Biol. Endocrinol. 9, 9. https:\/\/doi.org\/10.1186\/1477-7827-9-9 (2011).","journal-title":"Reprod. Biol. Endocrinol."},{"key":"85915_CR45","doi-asserted-by":"publisher","first-page":"485","DOI":"10.1007\/s10815-014-0186-3","volume":"31","author":"Q Lu","year":"2014","unstructured":"Lu, Q. et al. Low testosterone levels in women with diminished ovarian reserve impair embryo implantation rate: A retrospective case-control study. J. Assist. Reprod. Genet. 31, 485\u2013491. https:\/\/doi.org\/10.1007\/s10815-014-0186-3 (2014).","journal-title":"J. Assist. Reprod. Genet."},{"key":"85915_CR46","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1016\/j.rbmo.2018.10.006","volume":"38","author":"KA Walters","year":"2019","unstructured":"Walters, K. A. et al. Steroid profiles by liquid chromatography-mass spectrometry of matched serum and single dominant ovarian follicular fluid from women undergoing IVF. Reprod. Biomed. Online 38, 30\u201337. https:\/\/doi.org\/10.1016\/j.rbmo.2018.10.006 (2019).","journal-title":"Reprod. Biomed. Online"},{"key":"85915_CR47","doi-asserted-by":"publisher","first-page":"673","DOI":"10.1007\/s10815-018-1383-2","volume":"36","author":"M Noventa","year":"2019","unstructured":"Noventa, M. et al. Testosterone therapy for women with poor ovarian response undergoing IVF: A meta-analysis of randomized controlled trials. J. Assist. Reprod. Genet. 36, 673\u2013683. https:\/\/doi.org\/10.1007\/s10815-018-1383-2 (2019).","journal-title":"J. Assist. Reprod. Genet."},{"key":"85915_CR48","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1093\/humupd\/dmz046","volume":"26","author":"Y Zhang","year":"2020","unstructured":"Zhang, Y. et al. Adjuvant treatment strategies in ovarian stimulation for poor responders undergoing IVF: A systematic review and network meta-analysis. Hum. Reprod. Update 26, 247\u2013263. https:\/\/doi.org\/10.1093\/humupd\/dmz046 (2020).","journal-title":"Hum. Reprod. Update"},{"key":"85915_CR49","doi-asserted-by":"publisher","first-page":"13505","DOI":"10.1002\/14651858.Cd013505","volume":"12","author":"A Sharpe","year":"2019","unstructured":"Sharpe, A., Morley, L. C., Tang, T., Norman, R. J. & Balen, A. H. Metformin for ovulation induction (excluding gonadotrophins) in women with polycystic ovary syndrome. Cochrane Database Syst. Rev. 12, 13505. https:\/\/doi.org\/10.1002\/14651858.Cd013505 (2019).","journal-title":"Cochrane Database Syst. Rev."},{"key":"85915_CR50","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1111\/1471-0528.14754","volume":"125","author":"J Pundir","year":"2018","unstructured":"Pundir, J. et al. Inositol treatment of anovulation in women with polycystic ovary syndrome: A meta-analysis of randomised trials. BJOG 125, 299\u2013308. https:\/\/doi.org\/10.1111\/1471-0528.14754 (2018).","journal-title":"BJOG"},{"key":"85915_CR51","doi-asserted-by":"publisher","first-page":"2049","DOI":"10.1210\/en.2014-7534","volume":"155","author":"RJ Auchus","year":"2014","unstructured":"Auchus, R. J. Steroid assays and endocrinology: Best practices for basic scientists. Endocrinology 155, 2049\u20132051. https:\/\/doi.org\/10.1210\/en.2014-7534 (2014).","journal-title":"Endocrinology"},{"key":"85915_CR52","doi-asserted-by":"publisher","unstructured":"Practice Committee of the American Society for Reproductive Medicine. Electronic address, a. a. o. Definitions of infertility and recurrent pregnancy loss: a committee opinion. Fertil. Steril. 113, 533\u2013535, doi:https:\/\/doi.org\/10.1016\/j.fertnstert.2019.11.025 (2020).","DOI":"10.1016\/j.fertnstert.2019.11.025"},{"key":"85915_CR53","doi-asserted-by":"publisher","first-page":"1452","DOI":"10.1016\/j.fertnstert.2016.02.005","volume":"105","author":"G Poseidon","year":"2016","unstructured":"Poseidon, G. et al. A new more detailed stratification of low responders to ovarian stimulation: From a poor ovarian response to a low prognosis concept. Fertil. Steril. 105, 1452\u20131453. https:\/\/doi.org\/10.1016\/j.fertnstert.2016.02.005 (2016).","journal-title":"Fertil. Steril."},{"key":"85915_CR54","doi-asserted-by":"publisher","first-page":"791","DOI":"10.1093\/humrep\/det469","volume":"29","author":"MP Lauritsen","year":"2014","unstructured":"Lauritsen, M. P. et al. The prevalence of polycystic ovary syndrome in a normal population according to the Rotterdam criteria versus revised criteria including anti-Mullerian hormone. Hum. Reprod. 29, 791\u2013801. https:\/\/doi.org\/10.1093\/humrep\/det469 (2014).","journal-title":"Hum. Reprod."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-021-85915-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-021-85915-x","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-021-85915-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,3]],"date-time":"2022-12-03T00:34:55Z","timestamp":1670027695000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-021-85915-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,3,18]]},"references-count":54,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2021,12]]}},"alternative-id":["85915"],"URL":"https:\/\/doi.org\/10.1038\/s41598-021-85915-x","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-187757\/v1","asserted-by":"object"}]},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,3,18]]},"assertion":[{"value":"29 January 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 March 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 March 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"6336"}}